Article By:
NASDAQ GlobeNewswire
Monday, July 27, 2020 5:24 PM EDT
Zentalis Pharmaceuticals, Inc., today announced the commencement of a proposed underwritten public offering of 3,750,000 shares of its common stock.
In this article: ZNTL